Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Z. Surmeli · SciRah

Researcher profile · Semantic Scholar

Z. Surmeli

Share profile

Z. Surmeli — researcher profile on SciRah

h-index: 7
Works: 53
Citations: 140

Most-cited papers

Vitamin D deficiency and risk of Helicobacter pylori infection in older adults: a cross-sectional study
Deniz Mut Surmeli, Z. Surmeli, Remzi Bahşi, Tuğba Turgut +4 more
2018Aging Clinical and Experimental Research32 citations
Semantic Scholar
The Impact of Subtype Distribution in Inflammatory Breast Cancer Outcome.
B. Çakar, Z. Surmeli, P. Öner, Elif Sıla Yelim +2 more
2018European Journal of Breast Health20 citations Open access
Semantic Scholar
Programmed cell death ligand-1 expression in gastroenteropancreatic neuroendocrine tumors.
E. Oktay, G. Yalcin, S. Ekmekçi, D. S. Kahraman +11 more
2019Journal of B.U.ON. : official journal of the Balkan Union of Oncology14 citations
Semantic Scholar
Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment in patients with metastatic breast cancer.
Z. Surmeli, U. Varol, B. Çakar, M. Değirmenci +6 more
2015Oncology Letters14 citations Open access
Semantic Scholar
Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy
I. Yıldız, A. Bilici, N. Karadurmuş, L. Ozer +14 more
2018Tumori10 citations
Semantic Scholar
Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
B. Çakar, U. Varol, B. Junushova, U. Muslu +7 more
2013Journal of B.U.ON. : official journal of the Balkan Union of Oncology10 citations
Semantic Scholar
Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: a Multicenter Retrospective Turkish Oncology Group trial.
I. Yıldız, M. Ekenel, T. Akman, M. Koçar +12 more
2014Anticancer Research8 citations
Semantic Scholar
Primary tumor resection in metastatic breast cancer: A propensity‐matched analysis, 1988‐2011 SEER data base
Z. Surmeli
2018The Breast Journal5 citations Open access
Semantic Scholar
Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway
Z. Surmeli, Pinar Gursoy, A. Erdoğan, E. Bozkurt +6 more
2016Tumor Biology4 citations
Semantic Scholar
Prognostic value of ABO blood group in patients with nonseminomatous testicular cancer who treated with autologous stem cell transplantation
B. Yıldız, Ismail Erturk, N. Karadurmuş, Z. Surmeli +4 more
2018Journal of Oncological Sciences3 citations Open access
Semantic Scholar
Molecular biology (pre-clinical)
L. Malorni, M. Giuliano, I. Migliaccio, C. Creighton +115 more
20123 citations Open access
Semantic Scholar
Skeletal Muscle Loss During Neoadjuvant Chemotherapy for Breast Cancer: Diabetes as an Independent Predictor
Z. Surmeli, Ahmet Aslan, Mohamed F. Gado, Saifuddin Aljowder +6 more
2026European Journal of Breast Health2 citations Open access
Semantic Scholar
Epidemiology of Febrile Neutropenic and Bacteremic Patients in the Extensively Drug-Resistant Era
U. Elbahr, Amira Ahmed, Suha Hejres, Z. Surmeli +6 more
2024Archives of Clinical Infectious Diseases2 citations Open access
Semantic Scholar
Prognostic role of neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with docetaxel.
Atike Pinar, Ahmet Ozveren, Z. Surmeli, U. Şanlı +2 more
20152 citations
Semantic Scholar
Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancer.
U. Varol, E. Oktay, M. Yıldırım, Z. Surmeli +5 more
2014Molecular and clinical oncology2 citations Open access
Semantic Scholar
Clinical implications and prevalence of benign ethnic neutropenia (BEN) in breast cancer patients of Middle Eastern ethnicity.
Shruti Prem Sudha, A. Shehata, Fatema Sajjad, N. Abdelfattah +12 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Cisplatin-induced bone marrow failure in an adult patient with Fanconi anemia
Z. Surmeli, R. Ibrahim, Nawaf Alkhalfan, Zeyad Mahmood
2024Journal of Oncology Pharmacy Practice1 citations
Semantic Scholar
The Evaluation of Effificacy and Tolerability of Regorafenib Treatment in Metastatic Colorectal Cancer: Single Center Experience
B. Çakar, Z. Surmeli, Pınar Gürsoy, S. Güney +5 more
2019Turkiye Klinikleri Journal of Medical Sciences1 citations Open access
Semantic Scholar
Biweekly cetuximab in combination with platinum and 5-fluorouracil in metastatic head and neck carcinoma.
Z. Surmeli, Ahmet Ozveren, Ç. Arslan, M. Değirmenci +2 more
2019Indian Journal of Cancer1 citations
Semantic Scholar
Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study
N. Karadurmuş, S. Paydaş, E. Esin, Z. Surmeli +15 more
2019Archives of medical science : AMS1 citations Open access
Semantic Scholar
Sunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial.
I. Yıldız, M. Ekenel, T. Akman, M. Koçar +12 more
20141 citations Open access
Semantic Scholar
98P Octreotide in Combination with Docetaxel Triggers Apoptosis by Inducing Sstr2 and Sstr5 Levels in Human Breast Cancer Cells, Mcf-7 and Mda-Mb-231
B. Karaca, U. Muslu, Z. Surmeli, B. Çakar +6 more
20121 citations Open access
Semantic Scholar
Docetaxel/doxorubicin/cyclophosphamide (TAC) chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution.
Z. Surmeli, S. Aksoy, O. Dizdar, D. Dede +4 more
20101 citations
Semantic Scholar
Prognostic factors in long-term breast cancer survivors with brain metastases
H. Harputluoglu, A. Kara, O. Dizdar, Z. Surmeli +1 more
2008Breast Cancer Research and Treatment1 citations
Semantic Scholar
Clinical Implications and Prevalence of Duffy-Null Associated Neutrophil Count in Patients With Breast Cancer of Middle Eastern Ethnicity.
Shruti Prem Sudha, N. Abdelfattah, T. Yetişyiğit, T. Najeebi +14 more
2026JCO Global Oncology0 citations Open access
Semantic Scholar
Real-world data on clinical profile of immune-related adverse events (irAEs) associated with immune checkpoint inhibitors (ICIs) in oncology.
Shruti Prem Sudha, Sara Alhajeri, Alia Abdullatif, N. Abdelfattah +16 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Safety of Anthracyclines in Breast Cancer Patients with Glucose-6-Phosphate Dehydrogenase Deficiency
Z. Surmeli, Nawaf Alkhalfan, F. Faqihi, Fahir Öztürk +1 more
2025Journal of Oncological Sciences0 citations Open access
Semantic Scholar
Isolation Precautions Compliance Rates Among Healthcare Workers in a Tertiary Care Educational Hemato-Oncology Hospital
U. Elbahr, Nafisa Alwazzan, C. Reyes, Jennie Pastrana +7 more
2025Flora the Journal of Infectious Diseases and Clinical Microbiology0 citations Open access
Semantic Scholar
Letter to the editor: “Body composition measures as a determinant of alpelisib-related toxicity”
Z. Surmeli
2024Breast Cancer Research and Treatment0 citations Open access
Semantic Scholar
Outcomes of Everolimus Plus Endocrine Therapy Following CDK4/6 Inhibitor Therapy for Metastatic Hormone Receptor- Positive Breast Cancer
Z. Surmeli, Muhammad Sajid, Samrin Liaqat, Nawaf Alkhalfan
2024Journal of Oncological Sciences0 citations Open access
Semantic Scholar
Epidemiology of Rectal Cancer Patients in the Kingdom of Bahrain: A Retrospective Cohort Study
I. Juma, M. F. Saeed, Leonie R Hamel, Z. Ali +4 more
2024Euroasian Journal of Hepato-Gastroenterology0 citations Open access
Semantic Scholar
The Role of Age in Breast Cancer Subtypes: A Comparative Study in Young and Older Women
Hatice Özışık, A. Erdoğan, Z. Surmeli, F. Ekinci +2 more
2021Asian journal of Current Research in Clinical Cancer0 citations Open access
Semantic Scholar
Molecular subtypes of breast cancer in women ≤35 years and >35 years: Does age matter?
Hatice Ozisik, A. Erdoğan, Z. Surmeli, F. Ekinci +2 more
2021Clinical Cancer Investigation Journal0 citations
Semantic Scholar
Gene Arrays, Prognosis, and Therapeutic Interventions
Ç. Arslan, Z. Surmeli, Y. Ozisik
2019Breast Disease0 citations
Semantic Scholar
Retrospective analysis of patients with relapsed or refractory germ cell tumors treated with autologous hematopoietic stem cell transplantation
Ismail Erturk, B. Yıldız, N. Karadurmuş, Betul Tosun +7 more
20180 citations Open access
Semantic Scholar
Gastric adenocarcinoma with bone marrow carcinomatosis complicated with cancer related thrombotic microangiopathy: A case report
S. Gülle, E. Taşkıran, E. Gram, S. Ekmekçi +2 more
20170 citations Open access
Semantic Scholar
Effectiveness of bendamustine in relapse or refractory lymphoma cases: A report from Turkey—The Turkish Oncology Group (TOG) study.
N. Karadurmuş, S. Paydaş, R. Oçal, B. Yıldız +11 more
20170 citations
Semantic Scholar
A Retrospective Comparative Study Of Intrinsic Moleculer Breast Cancer Subtypes Between Young And Elderly Women With Breast Cancer.
G. Bulut, Z. Surmeli, M. Şahbazlar, U. Şanlı +3 more
20160 citations
Semantic Scholar
Prognostic effect of tumor location in stage II and III colon cancer.
Ahmet Ozveren, Z. Surmeli, Asli Turgut, B. Karaca +3 more
20150 citations
Semantic Scholar
Tumor infiltrating lymphocytes in cutaneous melanoma: Association with tumor characteristics and prognosis.
B. Karaca, Z. Surmeli, Atike Pinar, B. Karabulut +2 more
20150 citations
Semantic Scholar
1917 Prognostic role of surrogate intrinsic subtypes in non-metastatic inflammatory breast cancer
Z. Surmeli, B. Çakar, Pınar Gürsoy, B. Karabulut +2 more
20150 citations
Semantic Scholar
383PCOMPARISON OF MOLECULAR SUBTYPES OF BREAST CANCER IN WOMEN ≤35 YEARS AND > 35 YEARS: DOES AGE MATTER?
A. Erdoğan, B. Karaca, H. Yasdik, Z. Surmeli +3 more
2014Annals of Oncology0 citations Open access
Semantic Scholar
1597PTRASTUZUMAB/AT-101 COMBINATION INDUCES APOPTOSIS AND SHOWS SYNERGISTIC CYTOTOXICITY IN HER2-POSITIVE BREAST CANCER CELLS BY INHIBITION OF PI3K SIGNALING: A NOVEL COMBINATION TO OVERCOME RESISTANCE TO ANTI-HER2 THERAPY.
B. Karaca, Z. Surmeli, P. Gürsoy, A. Erdoğan +2 more
2014Annals of Oncology0 citations Open access
Semantic Scholar
Effect of trastuzumab/AT-101 combination on apoptosis and cytotoxicity in HER2-positive breast cancer cells: A novel combination to effect resistance to anti-HER2 therapy through inhibition of PI3K signaling.
B. Karaca, E. Bozkurt, H. Atmaca, Z. Surmeli +3 more
20140 citations
Semantic Scholar
Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel-resistant prostate cancer cells (PC-3/R and DU-145/R).
Z. Surmeli, E. Bozkurt, O. Ozer, H. Atmaca +4 more
20140 citations
Semantic Scholar
1121PPROGNOSTIC EFFECT OF PRIMARY TUMOR CHARACTERISTICS IN METASTATIC MELANOMA.
B. Karaca, Z. Surmeli, A. Erdoğan, U. Şanlı +2 more
2014Annals of Oncology0 citations Open access
Semantic Scholar
Trabectedin to induce mitochondrial membrane potential dissipation and reactive oxygen species generation in breast cancer cells.
H. Atmaca, E. Bozkurt, B. Çakar, Z. Surmeli +3 more
20130 citations
Semantic Scholar
P-0227COMPARISON OF SURVIVAL OF COLORECTAL CANCER PATIENTS UNDERGONE FOR METASTASECTOMY BEFORE OR AFTER CHEMOTHERAPY WITH LIVER ONLY METASTASES
B. Karaca, G. Bulut, Z. Surmeli, B. Çakar +4 more
20130 citations Open access
Semantic Scholar
P-0198DO TUMOUR CHARACTERISTICS AND DISEASE LOCALIZATION PREDICT BEVACIZUMAB ACTIVITY IN THE TREATMENT OF METASTATIC COLORECTAL CANCER?
U. Varol, E. Oktay, M. Yıldırım, Z. Surmeli +5 more
20130 citations Open access
Semantic Scholar
5PINTERPRETING GENOMIC DIVERSITY FOR BREAST CANCER: MOLECULAR SUBTYPES OF BREAST CANCER IN VERY YOUNG WOMEN (≤35 Y) IN WESTERN TURKEY
B. Karaca, H. Yasdik, Z. Surmeli, Pınar Gürsoy +4 more
20130 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Uslu×21
Invite
R. Uslu — researcher profile on SciRah
B. Karaca×21
Invite
B. Karaca — researcher profile on SciRah
U. Şanlı×14
Invite
U. Şanlı — researcher profile on SciRah
B. Karabulut×13
Invite
B. Karabulut — researcher profile on SciRah

×10

Invite

B. Çakar — researcher profile on SciRah

Invite

A. Erdoğan — researcher profile on SciRah

Invite

U. Varol — researcher profile on SciRah

Invite

H. Atmaca — researcher profile on SciRah

Invite

C. Sezgin — researcher profile on SciRah

N. Karadurmuş×5

Invite

N. Karadurmuş — researcher profile on SciRah

Invite

E. Bozkurt — researcher profile on SciRah

S. Uzunoğlu×5

Invite

S. Uzunoğlu — researcher profile on SciRah